George Bickerstaff, Director at Axovant Sciences Ltd. (AXON), bought 50,000 shares at $2.07 ($104K) on 2018-08-09, disclosed to the SEC on 2018-08-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.07 | 25,000 | $52K | 50.0% |
| 2 | $2.07 | 25,000 | $52K | 50.0% |
| Total | $2.07 avg | 50,000 | $104K | 100% |
| Filing → |
| CDNA | SELL | 2022-03-01 | $978K | — | Filing → |
| INVA | BUY | 2021-05-25 | $264K | — | Filing → |
| CDNA | SELL | 2021-05-21 | $1.5M | — | Filing → |